PLATINUM INVESTMENT MANAGEMENT LTD - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 98 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
PLATINUM INVESTMENT MANAGEMENT LTD ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$951,612
-25.0%
975,012
-20.1%
0.03%
-31.2%
Q4 2022$1,269,630
-9.6%
1,220,7980.0%0.05%
-18.6%
Q3 2022$1,404,000
-31.7%
1,220,798
+11.1%
0.06%
-24.4%
Q2 2022$2,055,000
-34.1%
1,098,888
+6.9%
0.08%
-18.8%
Q1 2022$3,116,000
-19.8%
1,028,3220.0%0.10%
-11.1%
Q4 2021$3,887,000
-26.9%
1,028,3220.0%0.11%
-28.0%
Q3 2021$5,316,000
+19.2%
1,028,322
-11.7%
0.15%
+45.6%
Q2 2021$4,461,000
+241.1%
1,164,746
+128.9%
0.10%
+255.2%
Q1 2021$1,308,000
+2.8%
508,7680.0%0.03%0.0%
Q4 2020$1,272,000
+20.8%
508,7680.0%0.03%
+11.5%
Q3 2020$1,053,000
-33.2%
508,7680.0%0.03%
-27.8%
Q2 2020$1,577,000
+127.6%
508,768
+67.4%
0.04%
+111.8%
Q1 2020$693,000
-37.0%
303,8660.0%0.02%
-22.7%
Q4 2019$1,100,000
+6.2%
303,8660.0%0.02%
-4.3%
Q3 2019$1,036,000
-44.7%
303,866
-23.7%
0.02%
-47.7%
Q2 2019$1,872,000
+12.9%
398,228
-19.5%
0.04%
+12.8%
Q1 2019$1,658,000
+26.0%
494,8290.0%0.04%
-11.4%
Q4 2018$1,316,000
+22.3%
494,829
+157.6%
0.04%
+41.9%
Q3 2018$1,076,000
+70.8%
192,100
+54.7%
0.03%
+106.7%
Q2 2018$630,000
-25.6%
124,2000.0%0.02%
-37.5%
Q1 2018$847,000124,2000.02%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 9,775,849$2,913,2031.93%
Aquilo Capital Management, LLC 3,303,190$984,3510.89%
CM Management, LLC 649,400$193,5210.20%
BVF INC/IL 20,609,863$6,141,7390.17%
WEALTH EFFECTS LLC 11,700$3,4870.00%
NJ State Employees Deferred Compensation Plan 30,000$8,9400.00%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 14,000$4,1720.00%
ACADIAN ASSET MANAGEMENT LLC 962,358$2860.00%
TWO SIGMA ADVISERS, LP 24,400$7,2710.00%
Tower View Wealth Management LLC 1,000$00.00%
View complete list of PIERIS PHARMACEUTICALS INC shareholders